The following communication, dated 19 October 2020, is being circulated at the request of the delegation of Brazil.
Reason for Addendum: | |
[ ] | Comment period changed - date: |
[ ] | Notified measure adopted - date: |
[ ] | Notified measure published - date: |
[ ] | Notified measure enters into force - date: |
[ ] | Text of final measure available from: |
[ ] | Notified measure withdrawn or revoked - date: Relevant symbol if measure re-notified: |
[X] | Content or scope of notified measure changed New deadline for comments (if applicable): |
[ ] | Interpretive guidance issued and text available from1: |
[X] | Other: href="https://www.in.gov.br/web/dou/-/resolucao-de-diretoria-colegiada-rdc-n-419-de-1-de-setembro-de-2020-275655953" https://www.in.gov.br/web/dou/-/resolucao-de-diretoria-colegiada-rdc-n-419-de-1-de-setembro-de-2020-275655953 |
Description: Resolution – RDC number 346, 1 March 2020 – previously notified through G/TBT/N/BRA/984 – which establishes extraordinary and temporary criteria and procedure for Good Manufacture Practice Guidelines for market authorization and post-market registration amendments of Active Pharmaceutical Ingredients, medicines, and healthcare products due to the international public health emergency of the new coronavirus (Covid-19), was changed by the Resolution – RDC number 419, 1 September 2020.